Epidemiology and Biostatistics Unit, Centro di Riferimento Oncologico - IRCCS, Via Gallini 2, 33081 Aviano (PN), Italy.
BMC Cancer. 2010 Jun 21;10:310. doi: 10.1186/1471-2407-10-310.
The incidence of invasive cervical cancer in HIV-positive women is higher than in the general population. There is evidence that HIV-positive women do not participate sufficiently in cervical cancer screening in Italy, where cervical cancer is more than 10-fold higher in women with AIDS than in the general population. The aim of the present study was to evaluate the history of Pap-smear in HIV-positive women in Italy in recent years. We also examined the sociodemographic, clinical, and organizational factors associated with adherence to cervical cancer screening.
A cross-sectional study was conducted between July 2006 and June 2007 in Emilia-Romagna region (Northern Italy). All HIV-positive women who received a follow-up visit in one of the 10 regional infectivology units were invited to participate. History of Pap-smear, including abnormal smears and subsequent treatment, was investigated through a self-administered anonymous questionnaire. The association between lack of Pap-smear in the year preceding the interview and selected characteristics was assessed by means of odds ratios (OR) and 95% confidence intervals adjusted for study centre and age.
A total of 1,002 HIV-positive women were interviewed. Nine percent reported no history of Pap-smear, and 39% had no Pap-smear in the year prior to the date of questionnaire (last year). The lack of Pap-smear in the last year was significantly associated with age <35 years (OR = 1.4, compared to age > or =45 years), lower education level (OR = 1.3), first HIV-positive test in the last 2 years (OR = 1.4), and CD4 count <200 cells/microl (OR = 1.6). Conversely, when women were advised by a gynecologist rather than other health workers to undergo screening, it significantly increased adherence. Non-significantly higher proportions of lack of Pap-smear in the last year were found in women born in Central-Eastern Europe (OR = 1.8) and Africa (OR = 1.3). No difference in history of Pap-smear emerged by mode of HIV-acquisition or AIDS status.Three hundred five (34%) women reported a previous abnormal Pap-smear, and of the 178 (58%) referred for treatment, 97% complied.
In recent years the self-reported history of Pap-smear in HIV-positive women, in some public clinics in Italy, is higher than previously reported, but further efforts are required to make sure cervical cancer screening is accessible to all HIV-positive women.
HIV 阳性妇女的宫颈癌发病率高于一般人群。有证据表明,意大利的 HIV 阳性妇女参与宫颈癌筛查的程度不够充分,在艾滋病患者中,宫颈癌的发病率比一般人群高 10 多倍。本研究旨在评估近年来意大利 HIV 阳性妇女的巴氏涂片检查史。我们还研究了与宫颈癌筛查依从性相关的社会人口统计学、临床和组织因素。
2006 年 7 月至 2007 年 6 月在意大利艾米利亚-罗马涅地区(北部)进行了一项横断面研究。所有在 10 个地区传染病学单位之一接受随访的 HIV 阳性妇女均被邀请参加。通过自行填写的匿名问卷,调查巴氏涂片检查史,包括异常涂片和随后的治疗情况。采用比值比(OR)和 95%置信区间(CI),调整研究中心和年龄后,评估巴氏涂片检查在前一年未进行与选定特征之间的关系。
共采访了 1002 名 HIV 阳性妇女。9%的人没有巴氏涂片检查史,39%的人在问卷日期(去年)前一年没有进行巴氏涂片检查。去年没有巴氏涂片检查与年龄<35 岁(与年龄≥45 岁相比,OR=1.4)、教育程度较低(OR=1.3)、最近 2 年内首次 HIV 阳性检测(OR=1.4)和 CD4 计数<200 个/微升(OR=1.6)显著相关。相反,如果妇女是由妇科医生而不是其他卫生工作者建议进行筛查,那么她们的依从性显著增加。在过去一年中,巴氏涂片检查未进行的比例在中欧和东欧(OR=1.8)和非洲(OR=1.3)出生的妇女中略高。获得 HIV 的方式或艾滋病状况不同,巴氏涂片检查史无差异。305 名(34%)妇女报告曾有过异常巴氏涂片检查,其中 178 名(58%)转诊接受治疗,97%的人接受了治疗。
近年来,意大利一些公共诊所的 HIV 阳性妇女自我报告的巴氏涂片检查史高于以往报告,但仍需进一步努力,确保所有 HIV 阳性妇女都能获得宫颈癌筛查。